James E. Pennington - 09 Jul 2021 Form 4 Insider Report for AzurRx BioPharma, Inc. (ENTO)

Role
CHIEF MEDICAL OFFICER
Signature
/s/ James E. Pennington
Issuer symbol
ENTO
Transactions as of
09 Jul 2021
Net transactions value
$0
Form type
4
Filing time
09 Jul 2021, 17:11:55 UTC
Next filing
03 Jan 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FWBI Stock option (right to buy) Award $0 +100,000 $0.000000 100,000 09 Jul 2021 Common stock, par value $0.0001 per share 100,000 $0.7500 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests in 36 equal monthly installments over a term of three (3) years beginning on the date of grant, conditioned on Mr. Pennington's continued employment by AzurRx BioPharma, Inc. on the applicable vesting date.